The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Morpholin-4-yl-N-{4-[4-((R)-pyrrolidin-3-ylamino)-thieno[3,2-d]pyrimidin-2-yl]-pyridin-2-yl}-benzamide ID: ALA3728175
PubChem CID: 89596371
Max Phase: Preclinical
Molecular Formula: C26H27N7O2S
Molecular Weight: 501.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cc(-c2nc(N[C@@H]3CCNC3)c3sccc3n2)ccn1)c1ccc(N2CCOCC2)cc1
Standard InChI: InChI=1S/C26H27N7O2S/c34-26(17-1-3-20(4-2-17)33-10-12-35-13-11-33)31-22-15-18(5-9-28-22)24-30-21-7-14-36-23(21)25(32-24)29-19-6-8-27-16-19/h1-5,7,9,14-15,19,27H,6,8,10-13,16H2,(H,28,31,34)(H,29,30,32)/t19-/m1/s1
Standard InChI Key: UJJXURHDFSFZGT-LJQANCHMSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 -3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 -3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4279 -5.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8944 -5.5664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6474 -4.2692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6464 -3.1521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9144 0.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2151 1.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2185 2.9892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9211 3.7421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6204 2.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9214 5.2429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6222 5.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6225 7.4952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5827 5.3949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3252 8.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3285 9.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6292 10.4953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9266 9.7424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9232 8.2424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6325 11.9960 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3363 12.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3420 14.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6439 14.9961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9401 14.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9344 12.7412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
11 10 1 6
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 16 1 0
20 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 24 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
28 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.62Molecular Weight (Monoisotopic): 501.1947AlogP: 3.62#Rotatable Bonds: 6Polar Surface Area: 104.30Molecular Species: BASEHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.31CX LogP: 3.74CX LogD: 0.96Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: -1.90
References 1. (2013) Thienopyrimidine inhibitors of atypical protein kinase C,